Anti-HLA-DR, Mouse-Mono(L243)

データシート

• 商品コード：NB100-77855
• メーカー：NOV
• 包装：0.1mg
• 価格： ¥96,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Hegde NR et al. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 2002 Nov;76(21):10929-41
  Hegde NR et al
  2002/01/01
  
• 備考：
  Species: Human, Applications: FLOW
• 参照：
  

• No.： 2
• 文献情報：
  Appel H et al. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells. J. Biol. Chem. 2000 Jan;275(1):312-21
  Appel H et al
  2000/01/01
  
• 備考：
  Species: Human
• 参照：
  

• No.： 3
• 文献情報：
  Setterblad N et al. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death. Transfusion 2008 Jan;48(1):169-77
  Setterblad N et al
  2008/01/01
  
• 備考：
  Species: Human, Applications: Func
• 参照：
  

• No.： 4
• 文献情報：
  Kabelitz D et al. Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression. Cell. Immunol. 1989 Apr;120(1):21-30
  Kabelitz D et al
  1989/01/01
  
• 備考：
  Species: Human, Applications: In vitro, Func
• 参照：
  

• No.： 5
• 文献情報：
  Kostelny SA et al. Humanization and characterization of the anti-HLA-DR antibody 1D10. Int. J. Cancer 2001 Aug;93(4):556-65
  Kostelny SA et al
  2001/01/01
  
• 備考：
  Species: Human, Applications: ELISA, Func
• 参照：
  

• No.： 6
• 文献情報：
  Chen YX et al. Characterization and expression of the HLA-DC antigens defined by anti-Leu 10. Hum. Immunol. 1984 Aug;10(4):221-35
  Chen YX et al
  1984/01/01
  
• 備考：
  Species: Human, Applications: FLOW, IHC-Fr
• 参照：
  

• No.： 7
• 文献情報：
  Apps R et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009 May;127(1):26-39
  Apps R et al
  2009/01/01
  
• 備考：
  Species: Human, Applications: FLOW
• 参照：
  

• No.： 8
• 文献情報：
  Ivanov A et al. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J. Clin. Invest. 2009 Aug;119(8):2143-59
  Ivanov A et al
  2009/01/01
  
• 備考：
  Species: Human, Applications: Func, In vitro
• 参照：
  

• No.： 9
• 文献情報：
  Gehring AJ et al. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect. Immun. 2003 Aug;71(8):4487-97
  Gehring AJ et al
  2003/01/01
  
• 備考：
  Species: Human, Applications: B/N
• 参照：
  

• No.： 10
• 文献情報：
  Patil NS et al. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles. J. Immunol. 2001 Dec;167(12):7157-68
  Patil NS et al
  2001/01/01
  
• 備考：
  Applications: IP, FLOW
• 参照：
  

• No.： 11
• 文献情報：
  Herman A et al. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc. Natl. Acad. Sci. U.S.A. 1991 Nov;88(22):9954-8
  Herman A et al
  1991/01/01
  
• 備考：
  Species: Human, Applications: FLOW
• 参照：
  

• No.： 12
• 文献情報：
  van Ham M et al. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J. Exp. Med. 2000 Apr;191(7):1127-36
  van Ham M et al
  2000/01/01
  
• 備考：
  Species: Human, Applications: ELISA, FLOW
• 参照：
  

• No.： 13
• 文献情報：
  H旦hn H et al. CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7. J. Immunol. 1999 Nov;163(10):5715-22
  H旦hn H et al
  1999/01/01
  
• 備考：
  Species: Human, Applications: FLOW, B/N, Func
• 参照：
  

• No.： 14
• 文献情報：
  Ulvestad E et al. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology 1994 Aug;82(4):535-41
  Ulvestad E et al
  1994/01/01
  
• 備考：
  Species: Human, Applications: IHC-Fr, ICC-IF, Func
• 参照：
  

• No.： 15
• 文献情報：
  Bertho N et al. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J. Immunol. 2000 Mar;164(5):2379-85
  Bertho N et al
  2000/01/01
  
• 備考：
  
• 参照：
  

• No.： 16
• 文献情報：
  Robbins PA et al. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. Hum. Immunol. 1987 Apr;18(4):301-13
  Robbins PA et al
  1987/01/01
  
• 備考：
  
• 参照：
  

• No.： 17
• 文献情報：
  Ovsyannikova IG et al. Identification of HLA-DRB1-bound self-peptides following measles virus infection. J. Immunol. Methods 2005 Feb;297(1-2):153-67
  Ovsyannikova IG et al
  2005/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Pashine A et al. Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 2003 Aug;19(2):183-92
  Pashine A et al
  2003/01/01
  
• 備考：
  
• 参照：
  

• No.： 19
• 文献情報：
  Wahlstr旦m J et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J. Clin. Invest. 2007 Nov;117(11):3576-82
  Wahlstr旦m J et al
  2007/01/01
  
• 備考：
  
• 参照：
  

• No.： 20
• 文献情報：
  Dengjel J et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. U.S.A. 2005 May;102(22):7922-7
  Dengjel J et al
  2005/01/01
  
• 備考：
  
• 参照：
  

• No.： 21
• 文献情報：
  Petersen SH et al. The role of tetraspanin CD63 in antigen presentation via MHC class II. Eur. J. Immunol. 2011 Sep;41(9):2556-61
  Petersen SH et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 22
• 文献情報：
  Chicz RM et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993 Jul;178(1):27-47
  Chicz RM et al
  1993/01/01
  
• 備考：
  
• 参照：
  

• No.： 23
• 文献情報：
  Doebele RC et al. Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 2000 Oct;13(4):517-27
  Doebele RC et al
  2000/01/01
  
• 備考：
  
• 参照：
  

• No.： 24
• 文献情報：
  Schick MR et al. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules. J. Immunol. 1993 Oct;151(8):4090-7
  Schick MR et al
  1993/01/01
  
• 備考：
  
• 参照：
  

• No.： 25
• 文献情報：
  Bainbridge DR et al. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J. Reprod. Immunol. 2000 Aug;48(1):17-26
  Bainbridge DR et al
  2000/01/01
  
• 備考：
  
• 参照：
  

• No.： 26
• 文献情報：
  Texier C et al. HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol. 2000 Mar;164(6):3177-84
  Texier C et al
  2000/01/01
  
• 備考：
  
• 参照：
  

• No.： 27
• 文献情報：
  Shibutani M et al. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study. BMC Cancer 2018 04;18(1):371
  Shibutani M et al
  2018/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 28
• 文献情報：
  Liu L et al. Endothelial Cell-Derived Interleukin-18 Released During Ischemia Reperfusion Injury Selectively Expands T Peripheral Helper Cells to Promote Alloantibody Production. Circulation 2020 02;141(6):464-478
  Liu L et al
  2020/01/01
  
• 備考：
  
• 参照：
  

• No.： 29
• 文献情報：
  Mo Y et al. Imaging and analysis on the interaction between human antigen-pulsed Vδ2 T cells and antigen-specific CD4 T cells. STAR Protoc 2021 Jun;2(2):100453
  Mo Y et al
  2021/01/01
  
• 備考：
  
• 参照：